RU2017109814A3 - - Google Patents

Download PDF

Info

Publication number
RU2017109814A3
RU2017109814A3 RU2017109814A RU2017109814A RU2017109814A3 RU 2017109814 A3 RU2017109814 A3 RU 2017109814A3 RU 2017109814 A RU2017109814 A RU 2017109814A RU 2017109814 A RU2017109814 A RU 2017109814A RU 2017109814 A3 RU2017109814 A3 RU 2017109814A3
Authority
RU
Russia
Application number
RU2017109814A
Other languages
Russian (ru)
Other versions
RU2017109814A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48289529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017109814(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2017109814A publication Critical patent/RU2017109814A/ru
Publication of RU2017109814A3 publication Critical patent/RU2017109814A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2017109814A 2011-11-10 2012-11-09 Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота RU2017109814A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011246209 2011-11-10
JP2011-246209 2011-11-10
JP2012071739 2012-03-27
JP2012-071739 2012-03-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014123567A Division RU2615509C2 (ru) 2011-11-10 2012-11-09 Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота

Publications (2)

Publication Number Publication Date
RU2017109814A RU2017109814A (ru) 2019-01-23
RU2017109814A3 true RU2017109814A3 (enExample) 2020-04-08

Family

ID=48289529

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2014123567A RU2615509C2 (ru) 2011-11-10 2012-11-09 Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота
RU2017109814A RU2017109814A (ru) 2011-11-10 2012-11-09 Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2014123567A RU2615509C2 (ru) 2011-11-10 2012-11-09 Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота

Country Status (17)

Country Link
US (3) US9090587B2 (enExample)
EP (2) EP2778159B1 (enExample)
JP (4) JP5871948B2 (enExample)
KR (2) KR102162208B1 (enExample)
CN (2) CN103930414B (enExample)
AU (1) AU2016273899B2 (enExample)
BR (1) BR112014010765B1 (enExample)
CA (1) CA2855022C (enExample)
ES (2) ES2747303T3 (enExample)
IN (1) IN2014DN03277A (enExample)
MX (1) MX375073B (enExample)
NZ (1) NZ623808A (enExample)
RU (2) RU2615509C2 (enExample)
SA (1) SA112330992B1 (enExample)
SG (2) SG11201401817TA (enExample)
TW (1) TWI547492B (enExample)
WO (1) WO2013069297A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP5651812B1 (ja) * 2013-04-25 2015-01-14 杏林製薬株式会社 固形医薬組成物
JP5700740B1 (ja) * 2013-04-25 2015-04-15 杏林製薬株式会社 固形医薬組成物
JP6349306B2 (ja) * 2013-04-25 2018-06-27 杏林製薬株式会社 錠剤
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
US20170246160A1 (en) * 2014-10-23 2017-08-31 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
JP6018334B2 (ja) * 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物
JP6077725B1 (ja) * 2015-03-13 2017-02-08 杏林製薬株式会社 呼吸器感染症治療剤
CA2988092A1 (en) 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
CA2987879A1 (en) 2015-06-02 2016-12-08 Kyorin Pharmaceutical Co., Ltd. Aqueous drug
US10206917B2 (en) * 2015-06-02 2019-02-19 Kyorin Pharmaceutical Co., Ltd. Aqueous drug
MX2019014931A (es) 2017-06-16 2020-02-13 Kyorin Seiyaku Kk Agente terapeutico para neumonia por aspiracion, supuracion pulmonar, o absceso pulmonar.
CN116549446A (zh) * 2017-06-16 2023-08-08 杏林制药株式会社 吸入性肺炎、肺化脓或肺脓肿的治疗剂
GB201808575D0 (en) 2018-05-24 2018-07-11 Galapagos Nv Methods for the treatment of psoriatic arthrits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA944369B (en) * 1993-08-27 1995-02-13 Hokuriku Seuyaku Co Ltd 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
CN1158846A (zh) * 1995-05-09 1997-09-10 昆山市康壮达兽药厂 盐酸氟哌酸的合成工艺
US20030124028A1 (en) * 2001-08-10 2003-07-03 Carlson Eric D. Apparatuses and methods for creating and testing pre-formulations and systems for same
JPWO2003076428A1 (ja) * 2002-03-08 2005-07-07 第一製薬株式会社 キノロンカルボン酸誘導体
DK1666477T3 (da) 2003-09-10 2013-07-29 Kyorin Seiyaku Kk 7-(4-trisubstitueret 3-cyclopropylaminomethyl-1- pyrrolidinyl)-quinoloncarboxylsyre-derivat
CN101003540A (zh) * 2006-01-18 2007-07-25 广州白云山制药股份有限公司广州白云山制药总厂 一种抗感染化合物和用途
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي

Also Published As

Publication number Publication date
CA2855022C (en) 2019-05-07
NZ623808A (en) 2015-07-31
RU2615509C2 (ru) 2017-04-05
JP2018158949A (ja) 2018-10-11
CA2855022A1 (en) 2013-05-16
JP5871948B2 (ja) 2016-03-01
AU2016273899B2 (en) 2017-07-27
ES2747303T3 (es) 2020-03-10
US9328089B2 (en) 2016-05-03
JP6349435B2 (ja) 2018-06-27
AU2012337206A8 (en) 2016-09-22
AU2016273899A1 (en) 2017-01-12
RU2017109814A (ru) 2019-01-23
KR20190065456A (ko) 2019-06-11
RU2014123567A (ru) 2015-12-20
BR112014010765B1 (pt) 2020-07-14
TWI547492B (zh) 2016-09-01
EP3112359B1 (en) 2019-08-21
EP2778159B1 (en) 2017-03-01
US20150284361A1 (en) 2015-10-08
ES2621664T3 (es) 2017-07-04
USRE47785E1 (en) 2019-12-31
CN103930414B (zh) 2016-01-20
AU2012337206A1 (en) 2014-05-22
CN104945375B (zh) 2017-07-04
CN103930414A (zh) 2014-07-16
EP2778159A1 (en) 2014-09-17
AU2012337206B2 (en) 2016-09-15
TW201332991A (zh) 2013-08-16
US9090587B2 (en) 2015-07-28
EP3112359A1 (en) 2017-01-04
BR112014010765A2 (pt) 2017-06-13
JP6514069B2 (ja) 2019-05-15
CN104945375A (zh) 2015-09-30
JP2017160243A (ja) 2017-09-14
WO2013069297A1 (ja) 2013-05-16
SG10201608167UA (en) 2016-11-29
EP2778159A4 (en) 2015-06-03
SG11201401817TA (en) 2014-08-28
SA112330992B1 (ar) 2015-09-13
KR102162208B1 (ko) 2020-10-06
KR20140098074A (ko) 2014-08-07
JP6818719B2 (ja) 2021-01-20
JPWO2013069297A1 (ja) 2015-04-02
IN2014DN03277A (enExample) 2015-05-22
US20140288310A1 (en) 2014-09-25
JP2016027045A (ja) 2016-02-18
MX375073B (es) 2025-03-06

Similar Documents

Publication Publication Date Title
BR112013022641A2 (enExample)
BR112013031251A2 (enExample)
BR112013027245A2 (enExample)
BR112013024383A2 (enExample)
BR112013023185A2 (enExample)
BR112013022995A2 (enExample)
BR112013026905A2 (enExample)
BR112013017670A2 (enExample)
BR112013027830A2 (enExample)
AP3853A (enExample)
BR112013026744A2 (enExample)
BR112013023927A2 (enExample)
BR112013027452A2 (enExample)
BR112013024365A2 (enExample)
BR112013028733A2 (enExample)
BR112013027121A2 (enExample)
BR112013024588A2 (enExample)
BR112013031556A2 (enExample)
BR112013026790A2 (enExample)
BR112013032366A2 (enExample)
BR112013032377A2 (enExample)
BR112013032380A2 (enExample)
BR112013027836A2 (enExample)
BR112013018949A2 (enExample)
BR112013026895A2 (enExample)